NCT03114254View on ClinicalTrials.gov

A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 5, 2014

Primary Completion Date

November 16, 2016

Study Completion Date

November 16, 2016

Conditions
Penile Neoplasm
Interventions
DRUG

Cabazitaxel

"Six cycles of chemotherapy comprising:~Cabazitaxel 25mg/m2 to be repeated at intervals of 21 days."

Trial Locations (2)

BS2 8ED

Bristol Haematology and Oncology Centre, Horfield Road, Bristol

Unknown

Universitty College Hospitals NHS Trust, London

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

NCT03114254 - A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis | Biotech Hunter | Biotech Hunter